Breaking Up the C Complex Spliceosome Shows Stable Association of Proteins with the Lariat Intron Intermediate by Coltri, Patricia et al.
Breaking Up the C Complex Spliceosome Shows Stable




1,2, Robert J. Chalkley
3, A. L. Burlingame
3, Melissa S. Jurica
1,2*
1Department of Molecular, Cell and Developmental Biology, University of California Santa Cruz, Santa Cruz, California, United States of America, 2Center for Molecular
Biology of RNA, University of California Santa Cruz, Santa Cruz, California, United States of America, 3Department of Pharmaceutical Chemistry, University of California San
Francisco, San Francisco, California, United States of America
Abstract
Spliceosome assembly requires several structural rearrangements to position the components of the catalytic core. Many of
these rearrangements involve successive strengthening and weakening of different RNA:RNA and RNA:proteins interactions
within the complex. To gain insight into the organization of the catalytic core of the spliceosome arrested between the two
steps of splicing chemistry (C complex), we investigated the effects of exposing C complex to low concentrations of urea.
We find that in the presence of 3M urea C complex separates into at least three sub-complexes. One sub-complex contains
the 59exon, another contains the intron-lariat intermediate, and U2/U5/U6 snRNAs likely comprise a third sub-complex. We
purified the intron-lariat intermediate sub-complex and identified several proteins, including U2 snRNP and PRP19 complex
(NTC) components. The data from our study indicate that U2 snRNP proteins in C complex are more stably associated with
the lariat-intron intermediate than the U2 snRNA. The results also suggest a set of candidate proteins that hold the lariat-
intron intermediate together in C complex. This information is critical for further interpreting the complex architecture of
the mammalian spliceosome.
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Introduction
Pre-mRNA splicing is an essential step in eukaryotic gene
regulation. The excision of introns coupled to exon ligation to
form mRNA molecules is performed by the spliceosome, a huge
macromolecular machinery composed of five snRNPs (U1, U2,
U4/U6 and U5 snRNAs associated with proteins) and many
additional splicing factors. In total the complex comprises
approximately 175 components [1]. Spliceosome assembly at
each intron is a dynamic process, and formation of a catalytically
competent complex is dependent on rearrangements of many
RNA:RNA, RNA:protein and protein:protein interactions [2,3,4].
One of many examples of spliceosome dynamics is the extensive
and shifting interaction network of U2 snRNP during spliceosome
assembly and catalysis. Changes in internal U2 snRNA base
pairing, base pairing with the pre-mRNA and U6 snRNA have
been demonstrated [5,6,7]. U2 snRNA:protein interactions also
evolve during spliceosome assembly. For example, when com-
pared to the isolated 17S U2 snRNP particle, crosslinking of
proteins with the U2 snRNA, 59 splice site and branchpoint
regions changed progressively in both A and B complexes [8].
Although far from fully understood, U2 snRNP protein interac-
tions within the snRNP and with other spliceosome components
also exist and change during splicing.
Many other interactions (and their changes) within the
spliceosome have been described. However, given the numerous
players and large combinatorial potential for interactions, a clear
picture of the arrangement of the spliceosome’s many components
and their intermolecular associations would be helpful, but is not
currently available. For example, little is known about the
dynamics of the Prp19 complex (NTC) and its associated proteins,
which join the spliceosome at some point during B complex
formation [9]. NTC plays roles in modulating the interactions of
both U6 and U5 snRNAs with pre-mRNA during spliceosome
activation [10,11]. Genetic evidence supports a role for the core
NTC protein Isy1 in promoting first step fidelity in conjunction
with the ATPase Prp16 [12]. However, the interactions that
mediate these functions are not known. Direct interactions
between NTC core proteins and other spliceosome proteins have
not been characterized, although NTC-associated proteins Cwc21
and Cwc2 have been shown to interact with Prp8 and U6
snRNAs, respectively [13].
Working toward the goal of characterizing the interactions
within the catalytic core of the spliceosome that lead to specific
positioning of pre-mRNA and splicing, we examined the stability
of interactions of pre-mRNA with spliceosomal core components
after the first step of chemistry (i.e. in C complex spliceosomes).
PLoS ONE | www.plosone.org 1 April 2011 | Volume 6 | Issue 4 | e19061We find that the 59 exon and lariat intermediate disassociate in the
presence of 3M urea, but are not entirely stripped of binding
proteins. Closer examination of the lariat intermediate reveals that
several U2 snRNP proteins, NTC proteins and other spliceosome
proteins remain associated. Our results address the hierarchy of
complex protein-RNA interactions in C complex, which will be
important for modeling spliceosome structures in the future.
Results
The 59 exon and lariat-intron intermediate in C complex
spliceosomes disassociate in 3M urea
In order to assess the stability of core C complex spliceosomes
we exposed purified complexes to increasing concentrations of
urea and examined their sedimentation behavior in glycerol
velocity gradients. As previously described [14] we first assembled
C complex spliceosomes in HeLa nuclear extracts on a pre-mRNA
splicing substrate that harbors an AGRGG mutation at the 39
splice site. This splicing substrate goes through the first step of
chemistry, yielding a cleaved 59 exon and lariat-intron interme-
diate, but the second step is blocked due to the 39 splice site
mutation, and a population of C complex spliceosomes accumu-
lates. We isolated the splicing complexes by an MS2:MBP affinity
tag located in the intron of the pre-mRNA under native
conditions. We then treated the isolated complexes with varying
amounts of urea before sedimentation in a linear (10–30%)
glycerol gradient. To follow the complexes, we examined the
radiolabeled pre-mRNA splicing intermediates extracted from
gradient fractions by denaturing gel analysis.
With no urea treatment, both 59 exon and lariat-intron
intermediates of C complex peak in the same gradient fractions
(fraction 7–8) in equimolar amounts, which is expected for the
intact complex [14] (Figure 1A). In contrast, after completely
disrupting the complex by phenol extraction to obtain protein-free
Figure 1. Glycerol gradient profiles of purified C complex spliceosomes. All three panels show denaturing gel analysis of RNA from linear
(10–30%) glycerol gradient sedimentation of (a) native, (b) phenol-extracted and (c) 3M urea-treated C complex spliceosomes. Fractions numbers
from the top to the bottom of the gradient are indicated. Splicing intermediates are indicated on the left. From top to bottom: lariat-intron
intermediate, pre-mRNA, digested pre-mRNA and 59 exon. The digested pre-mRNA arises from RNase H mediated cleavage of substrate that did not
incorporated into C complex during spliceosome assemble as detailed in [14]. The panels on the right show the normalized quantifications of 59 exon
(black) and lariat-intron (grey) intermediates in glycerol gradient fractions.
doi:10.1371/journal.pone.0019061.g001
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peak at the top gradient in fraction 2 (Figure 1B). Treating
complexes with 1M urea prior to gradient fractionation did not
alter the mobility of the splicing intermediates, suggesting that they
remain together in a complex (Figure S1). However, when we
incubated the complexes in 3M urea, we found that the 59 exon
and lariat-intron intermediate no longer sediment in the same
fractions. Instead the 59 exon peak shifted two fractions upward in
the gradient to fraction 5, while the lariat-intron intermediate was
concentrated between fractions 6 and 7 (Figure 1C). Based on
these results, we hypothesized that 3M urea disrupts key
interactions stabilizing C complex and leads to its separation into
at least two sub-complexes, one of which contains the 59 exon and
other containing the lariat-intron intermediate. It is possible that
some proteins disassociated from the splicing intermediates with
the urea treatment. However, because neither RNA species moved
to the top of the gradient like protein-free RNA, we infer that some
spliceosome components remain associated with both the 59 exon
and the lariat-intron intermediate.
To explore this hypothesis, we investigated the profile of
spliceosomal snRNAs from repeated gradient fractionation of
native and 3M urea treated C complexes. Northern analysis for
the five U snRNAs, show that U2, U5 and U6 snRNAs co-migrate
with both splicing intermediates in native C complex, as previously
demonstrated [14] (Figure 2A). With 3M urea treatment, however,
all three snRNAs follow the 59 exon shift and peak together three
fractions higher in the gradient (Figure 2B). Although this result is
suggestive of a complex containing the 59 exon and snRNAs, the
data do not differentiate between this possibility and the possibility
of two or more separate snRNA sub-complexes.
Isolation of separate intron-intermediate and 59 exon
complexes
In order to examine the complexes associated with the splicing
intermediates more closely, we sought to isolate them separately.
We altered our C complex purification protocol to add a 3M urea
wash step at the point where C complex is bound to amylose resin
just prior to affinity elution with maltose (Figure 3). As predicted
Figure 2. Glycerol gradient profiles of spliceosomal U snRNAs associated with purified C complex spliceosomes. The two panels show
northern blots using probes against U1, U2, U4, U5, U6 snRNAs for (a) native and (b) 3M urea-treated C complex spliceosomes fractionated on
glycerol gradients. Fractions numbers from the top to the bottom of the gradient are indicated. Splicing intermediates and snRNAs are indicated on
the left. The panels on the right show the quantifications of 59 exon (grey), lariat-intron intermediate (black) and the 3 snRNAs found in C complex
(U2, blue; U5, green; U6, orange). C is native C complex; NE is nuclear extract control.
doi:10.1371/journal.pone.0019061.g002
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elutes in the urea fractions, while the MS2:MBP tagged lariat-
intron intermediate is largely retained on the column. Subsequent
addition of maltose (3–10 mM) elutes the lariat-intron intermedi-
ate separately (Figure 3A). When we move the MS2:MBP tag from
the intron to the 59 exon of the splicing substrate, we obtain the
reverse situation: lariat-intron intermediate elutes with the urea
wash, while the 59 exon is retained until maltose elution
(Figure 3B). These results show that we can enrich for either
RNA species separately. It also supports our hypothesis that 3M
urea treatment disrupts interactions that hold the 59 exon and
lariat-intron intermediate together in C complex after the first step
of chemistry.
In order to address the potential association of snRNPs with the
59 exon, we performed northern blots for the spliceosomal U
snRNAs in peak fractions from urea and maltose elution of C
complex assembled on pre-mRNA substrate with the MS2:MBP
tag in either the intron or 59 exon. With either tagged substrate, we
find the U2, U5 and U6 snRNAs in the urea elution (Figure 4).
This result indicates that the U snRNAs are not stably associated
with either 59 exon or lariat-intron intermediate after urea
treatment. It thus appears that 3M urea also disrupts interactions
stabilizing the association of the three U snRNAs with C complex.
From these experiments we cannot tell whether the snRNAs
remain in association with each other, although it may be
indicated by their co-sedimentation in glycerol gradients even after
urea treatment (see Figure 2). However, this aspect of the urea
treatment remains to be explored.
Several proteins remain associated with urea-washed
lariat-intron intermediate
We next questioned whether proteins remain bound to the
lariat-intron intermediate after urea treatment. Although it is
possible that 3M urea treatment may completely disrupt C
complex, the fact that both the 59 exon and lariat-intron
intermediate sediment significantly farther in glycerol gradients
relative to their naked RNA counterparts indicates that some
spliceosome components are still in complex. Furthermore, our
ability to purify the urea-washed splicing intermediates indicates
that at least the MS2:MBP protein remains bound to the RNA. To
determine which proteins disassociate from the lariat intermediate
with urea treatment and which proteins remain bound, we pooled
Figure 3. Purification of intron-lariat intermediate and 59 exon
subcomplexes. (a) Denaturing gel analysis of sample fractions taken
during purification with an intron-tagged pre-mRNA substrate. From
left to right: Indicated time points of splicing reaction in minutes,
fractions from 3M urea wash and maltose eluate. Splicing intermediates
and other RNA species are indicated on the left. From top to bottom:
lariat-intron intermediate, pre-mRNA, digested pre-mRNA that did not
assemble into splicing complexes and 59 exon. The asterisk indicates
species that contain the MS2:MBP affinity tag. Quantified below each
lane is the relative ratio lariat-intron intermediate to 59 exon. (b) The
same as (a) except that the affinity tag is located in the 59 exon of the
pre-mRNA substrate. In this case the splicing intermediates and other
RNA species are (from top to bottom) lariat-intron intermediate, pre-
mRNA, 39 end chew back product of lariat-intron intermediate, 59 exon
and digested pre-mRNA that did not assemble into splicing complexes.
The quantification below is the relative ratio of 59 exon to lariat-
intermediate species.
doi:10.1371/journal.pone.0019061.g003
Figure 4. snRNAs association with splicing intermediates after
3M urea treatment. Northern analysis probing for U1, U2, U4, U5 and
U6 snRNAs from purified C complex spliceosomes using (a) an intron-
tagged or (b) 59 exon-tagged pre-mRNA substrate. NE is nuclear extract
control. C is native C complex. U is 3M urea wash of C complex bound
to amylose resin. M is the subsequent elution with maltose. The asterisk
indicates the signal from the radiolabeled 59 exon.
doi:10.1371/journal.pone.0019061.g004
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assembled on a lariat-intron tagged substrate. We then subjected
those samples to protein identification by mass spectrometry (MS).
The results of this analysis are shown in Table 1.
For several proteins detected from lariat-intron tagged C
complex we see a clear enrichment when we compare of the
number of unique peptides sequenced in the urea vs. maltose
eluate. In cases where the difference between the number of
peptides found for each sub-complex was higher than 70% of the
total, we considered the protein enriched. For example, we
detected 77 unique peptides for the U5 snRNP protein Prp8 in the
urea eluate, but only 25 unique Prp8 peptides in the maltose
eluate. In contrast, we detected 22 peptides from the U2 snRNP
protein SF3b155 in the same maltose eluate, but no SF3b155
peptides in the urea eluate. For some proteins, there is no clear
enrichment, an example of which is U2-B0. We detected four U2-
B0 peptides in both the urea and maltose eluate. For some of the
other C complex proteins, we did not obtain large numbers of
peptides, making it difficult to strongly conclude differential
representation in the two samples.
In comparing the peptide numbers for the different C complex
proteins, there are several clear trends in the data. The number of
peptides for U5 snRNP proteins is greater in the urea eluate
relative to the maltose eluate, with the exception of the U5 40 kD
for which two peptides were in the urea wash sample vs. three in
the maltose eluate. In contrast, with the U2 SF3b complex
proteins that we detected, there were more peptides in the maltose
elution. Sm proteins, which are small and therefore yield fewer
peptides, were all enriched in the urea eluate. Whereas a number
of Prp19 complex (NTC) and NTC-associated proteins were
enriched in the urea eluate or nearly equally represented, several
were clearly enriched in the maltose eluate. Second step factors
Table 1. Mass spectrometry analysis of urea and maltose
eluates from C complex purification.
UniProt
accession Protein S.c. kDa Urea Maltose
Sm proteins:
P14678 SmB/B9 Smb1p 24 2
P62314 SmD1 Smd1p 13 32
P62316 SmD2 Smd2p 13 3
P62318 SmD3 Smd3p 14 32
P62304 SmE Sme1p 11 1
P62306 SmF Smf1p 10 2
U2 snRNP:
P09661 U2-A9 Lea1p 28 75
P08579 U2-B0 Msl1p 25 44
Q15459 SF3a120 Prp21p 88 24
O75533 SF3b155 Hsh155p 146 22
Q13435 SF3b150 Cus1p 98 11
Q15393 SF3b130 Rse1p 135 41 5
Q15427 SF3b50 Hsh49p 44 1
Q7RTV0 SF3b14 Rds3p 12 1
U5 snRNP:
Q6P2Q9 PRPF8 Prp8p 273 77 25
O75643 U5–200 kD Brr2p 244 56 18
Q15029 U5–116 kD Snu114p 109 13 10
Q96DI7 U5–40 kD 39 23
Recruited to B complex:
Q9HCG8 CWC22 Cwc22p 105 33
P23246 PSF 76 13 1
NTC:
Q9UMS4 PRP19 Prp19p 55 26 7
Q99459 CDC5L Cef1p 92 79
O75934 SPF27 Snt309p 26 91
O43660 PLRG1 Prp46p 57 17
NTC associated:
Q13573 SKIP Prp45p 61 72
Q9BZJ0 CRNL1 Clf1p 100 66
Q9HCS7 SYF1 Syf1p 100 21 3
Q9ULR0 ISY1 Isy1p 32 6
Q9NW64 RBM22 Ecm2p 47 6
Q9UNP9 PPIE 33 1
Q9Y3C6 PPIL1 18 1
Second step factors:
O95391 SLU7 Slu7p 68 2
O60508 PRP17 Prp17p 65 23
Q14562 DHX8 Prp22p 139 61 3
Recruited to C complex:
O60306 AQR 171 55 2
Q9Y314 NOSIP 33 3
Q96BP3 PPWD1 74 2
Q9UJV9 DDX41 70 2
Q9H2H8 PPIL3 18 1
O95926 GCIP-IP Syf2p 28 1
UniProt
accession Protein S.c. kDa Urea Maltose
Exon junction complex:
P38919 eIF4AIII 47 48
hnRNP/RNA binding proteins*:
Q13151 hnRNPA0 31 3
P09651 hnRNPA1 39 5
P22626 hnRNPA2/B1 37 2
P07910 hnRNPC 33 41 4
Q9UKM9 RALY 32 1
P26599 PTBP1 57 15
Q86U42 PABP2 32 1
Q9H875 PKRI1 21 1
Q96PU8 QKI 37 17
P43243 MATR3 94 17
Q9Y580 RBM7 30 2
Q15717 ELAV1 36 1
LC-MS/MS analysis of urea and maltose eluate of lariat-intron tagged C complex
spliceosome purification. Columns from left to right are the UniProt accession
number, human protein name, S. cerevisiae homolog name, molecular weight in
kDa, number of unique peptides used to identify a given protein in urea and
maltose eluates.
*These proteins have been previously shown to associate with pre-mRNA
under conditions that do not support splicing.
doi:10.1371/journal.pone.0019061.t001
Table 1.Cont.
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Slu7 peptides were only found in the urea eluate. Of the six C
complex specific proteins that we detected, only two, AQR
(IBP160) and NOSIP, yielded peptides enriched in the maltose
elution. Finally, peptides that we detected for many RNA-binding
proteins, which are likely not specific components of C complex
(ex. hnRNP proteins), nearly all were found only in the maltose
sample.
Although MS analysis is not strictly quantitative, there is a
strong correlation between the number of peptides identified to a
given protein and its amount [15]. Hence, differential peptide
numbers in the urea vs. maltose elution for a given protein
provides a measure of its association with the tagged lariat-intron
intermediate. We tested this idea for two spliceosome proteins by
western analysis of the urea and maltose eluates (Figure 5). In
agreement with our hypothesis, we observe a significant
enrichment of U2 SF3b130 in the maltose eluate of the lariat-
intron tagged substrate relative to the urea eluate. This correlates
well with the MS results for this protein, which showed 15 peptides
in the maltose sample vs. four in the urea sample. In contrast, if the
affinity tag is located in the 59 exon of the pre-mRNA substrate
such that lariat-intron intermediate is released during the urea
wash, we observe the reverse situation: SF3b130 is enriched in the
urea vs. maltose samples. With the U5 snRNP protein Prp8 we see
enrichment in the urea eluate relative to the maltose eluate with
the intron-tagged pre-mRNA substrate, again consistent with MS
results discussed above. These results support our hypothesis that
some proteins remain stably associated with the lariat intermediate
in 3M urea, while others do not.
Discussion
The composition and gross structure of C complex have been
characterized, however the relative spatial arrangement of
spliceosomal components in that structure has not been deter-
mined. Years of biochemical and genetic studies have defined
several subcomplexes of spliceosomal components and many
direct interactions between these components, which provide
important clues to their relative positions. However, the multitude
of components and dynamic complexity of the spliceosome as it
evolves during the splicing cycle leaves much still to learn about
the architecture of the complex. In this study we explore a set of
stable interactions in C complex spliceosomes. We find several
proteins that remain stably bound to the lariat intermediate in the
presence of low concentrations of urea, while many other
spliceosome components are released with this treatment. While
a number of the bound proteins are known to interact with RNA
and are likely associated by directly binding the lariat intermediate
(ex. MS2:MBP and hnRNP proteins), it is likely that some of the
associated proteins are retained through stable protein-protein
interactions. These proteins are good candidates for mediating
interactions within C complex that assist in holding both
intermediates together. For example, we find the SF3b trimer of
the 155, 150 and 130 kD proteins all enriched. Currently there is
evidence to support only SF3b150kD interaction with pre-mRNA
in C complex [16,17], and the other SF3b proteins likely remain
through their stable interactions with each other and potentially
other spliceosome proteins. Although SF3b has been shown to
interact directly with U2 snRNA in the U2 snRNP [18], release of
U2 snRNA from C complex with the urea treatment is not
surprising. During activation of splicing, U2 snRNA becomes
extensively base paired with U6 snRNA, which likely requires a
change in its association with U2 snRNP proteins. In fact after
urea treatment we find U2 migrating with U6 snRNAs on glycerol
gradients. It has been recently noted that SF3Bs association with
the spliceosome is destabilized during Prp2 mediated spliceosome
activation, which may be a reflection of its having ‘‘let go’’ of the
U2 snRNA [19,20].
In addition to the SF3B proteins, several proteins associated
with the NTC show striking peptide enrichment with the lariat
intron. These include PLRG1 (WD40 motif), SYF1 (HEAT
repeat), ISY1 (no obvious motifs) and RBM22 (RRM, zinc finger).
Of these, only RBM22 has an RNA-binding motif, making it a
potential candidate for directly binding to the lariat-intron
intermediate. Alternatively or additionally, these NTC-associated
proteins may associate with the lariat-intron intermediate via
interactions with SF3B proteins.
Two other proteins that show significant enrichment with the
intron are AQR and DHX8 (Prp22), both of which contain
helicase motifs. DHX8 is a second step factor and has been shown
to be important for exon ligation and mRNA release from the
spliceosome in yeast [21,22,23]. The yeast homolog Prp22 has
been shown to contact the 39 exon following the second step of
chemistry, but no data yet shows a direct interaction with pre-
mRNA in C complex. AQR, which joins the spliceosome at or
after the first step of chemistry, is also known as intron-binding
protein 160 (IBP160) and has been shown to crosslink upstream of
the branchpoint sequence [24].
After the first step of splicing it is imperative that the
spliceosome retains a tight grip on the splicing intermediates to
ensure proper exon ligation. Although several interactions
between the pre-mRNA and snRNAs or proteins have been
demonstrated, our understanding of this critical function of the
spliceosome is far from complete. The data from our study provide
a set of candidate proteins that hold the lariat-intron intermediate
in C complex. Furthermore, they suggest a measure of stability
between interaction partners for several spliceosome proteins at
this stage of spliceosome progression. For example, SF3b’s
association with the lariat-intron intermediate appears to be
stronger than its interactions with U2 snRNA. With NTC
associated proteins, our data limit the number of potential
interaction partners that stabilize their association with the
lariat-intron intermediate. To date, very little is known about
how these proteins incorporate into the spliceosome, and our data
suggest that at this stage of the spliceosome some NTC
components interact more intimately with this core lariat-intron
complex than with other NTC members. This may be a reflection
of the orientation of the NTC and its associated proteins relative to
the lariat-intron intermediate and/or of a change in NTC
conformation in C complex. Our data also suggest intriguing
Figure 5. Association of SF3b130 and Prp8 with splicing
intermediates after 3M urea treatment. Western analysis of
purified C complex spliceosomes using an intron-tagged (I) or 59
exon-tagged (E) pre-mRNA substrate. NE is nuclear extract control. C is
native C complex. U is 3M urea wash of C complex bound to amylose
resin. M is the subsequent elution with maltose.
doi:10.1371/journal.pone.0019061.g005
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SF3b and/or other proteins that we identified in the stable lariat-
intron intermediate complex. Future studies using the approach
that we present here will certainly shed further clues for solving the




All pre-mRNA splicing substrates are a derivative of the
Adenovirus Major Late (AdML) transcript as a splicing substrate
[25] that contains an AGRGG 39 splice site mutation [26]. The
substrate was tagged with three MS2 phage coat protein-binding
sites in either the intron or 59 exon for affinity purification in
conjunction with a fusion of MS2 protein to maltose binding
protein (MS2:MBP).
C complex purification
As previously described [14] C complex spliceosomes were
assembled in an in vitro splicing reaction after which excess pre-
mRNA not incorporated into the spliceosome was digested by
endogeneous RNAse H by adding two DNA oligo nucleotides
complementary to the region 6–28 nt upstream of the 59 splice
site. The complexes were isolated by size exclusion followed by
affinity capture on amylose beads in 20 mM Tris, pH 7.9,
150 mM KCl, 0.5 mM EDTA (SCB1). Native C complexes were
eluted from amylose beads using 10 mM maltose in SCB1, as
previously described [14]. To isolate urea-washed complexes, the
amylose beads were incubated in 3M urea for 5 minutes at room
temperature. After collecting the resulting supernatant, the beads
were submitted to regular elution with maltose.
Glycerol gradient analyses
Native C complex or C complex incubated with 3M urea for
30 min at room temperature was centrifuged on a 600 mL linear
10–30% glycerol gradient prepared in SCB1 at 38,000 rpm for
2 h 30 min at 4uC using a Beckman SW 55 Ti rotor with tube
adaptors. Fifteen 40 mL fractions were collected from the top to
the bottom of the gradient. RNA from each fraction was extracted
with phenol/chloroform, ethanol precipitated and separated on a
15% denaturing acrylamide gel, which was visualized with a
phosphorimager (Molecular Dynamics) and quantified with
ImageQuant software (Molecular Dynamics).
Northern blots
For northern blots, 80 fmol of purified complexes and an
aliquot of HeLa nuclear extract were separated on a denaturing
10% polyacrylamide gel, transferred to a nylon membrane
(Immobilon, Millipore), UV crosslinked, and hybridized with
32P-labeled probes complementary to the U snRNAs [27].
Western blots
80 fmol of purified samples along with an aliquot of HeLa
nuclear extract were separated on a 10% SDS-PAGE, transferred
to a nitrocellulose membrane and probed with either anti-
SF3b130 or anti-PRPF8 (Proteintech). Following incubation with
anti-IgG rabbit (Santa Cruz Biotech) the membrane was
developed using the Super Sensitive Femto Kit (Pierce).
Mass spectrometry
For peptide sequence analysis by mass spectrometry, approx-
imately 500 fmol of purified complexes were separated by 10%
SDS-PAGE and stained with Coomassie-G. The gel lane was cut
into 8–10 sections, and each section subjected to in-gel tryptic
digestion. Proteins were reduced with 10 mM DTT for one hour
at 55C, then free sulfhydryls were alkylated using iodoacetamide
for one hour, after which proteins were digested overnight with
150 ng Promega modified trypsin.
Samples were analyzed using two different mass spectrometry
platforms, and then results were combined. Samples were
analyzed by LC-MS/MS using a Thermo LTQ-Orbitrap and a
MDS Sciex/Applied Biosystems QSTAR XL. One hour reverse-
phase chromatography separations were carried out using an
Eksigent nano-1D HPLC system attached to each mass spectrom-
eter. Peptides were selected for fragmentation analysis as they
eluted in a data-dependent fashion, and dynamic exclusion was
employed to prevent repeated analysis of the same components.
Data was searched using Protein Prospector developmental
version 4.25.4 (which was functionally similar to version 5.0 [28])
against the UniprotKB protein database downloaded on February
21
st 2007. For Orbitrap data, precursor and fragment mass
tolerances of 15 ppm and 0.6 Da respectively were allowed, and
for QSTAR data a precursor mass tolerance of 100 ppm and
fragment mass tolerance of 300 ppm was considered. Cysteines
were assumed to be carbamidomethylated, and methionine
oxidation, protein N-terminal acetylation and pyroglutamate
formation from N-terminal glutamine residues were all considered
as possible modifications. A maximum expectation value of 0.1
was employed as a threshold for peptide identifications.
Supporting Information
Figure S1 Glycerol gradient profile of C complex
spliceosomes treated with 1M urea. The image shows
denaturing gel analysis of RNA from linear (10–30%) glycerol
gradient. Fractions numbers from the top to the bottom of the
gradient are indicated. Splicing intermediates are indicated on the
left. From top to bottom: lariat-intron intermediate, pre-mRNA,
digested pre-mRNA and 59 exon.
(TIF)
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